rs3217422
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_000103.4(CYP19A1):c.*2258_*2259insA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.46 ( 16488 hom., cov: 0)
Exomes 𝑓: 0.50 ( 0 hom. )
Consequence
CYP19A1
NM_000103.4 3_prime_UTR
NM_000103.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.142
Publications
2 publications found
Genes affected
CYP19A1 (HGNC:2594): (cytochrome P450 family 19 subfamily A member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and catalyzes the last steps of estrogen biosynthesis. Mutations in this gene can result in either increased or decreased aromatase activity; the associated phenotypes suggest that estrogen functions both as a sex steroid hormone and in growth or differentiation. Alternative promoter use and alternative splicing results in multiple transcript variants that have different tissue specificities. [provided by RefSeq, Dec 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 15-51208549-A-AT is Benign according to our data. Variant chr15-51208549-A-AT is described in ClinVar as Benign. ClinVar VariationId is 316444.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.523 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000103.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CYP19A1 | NM_000103.4 | MANE Select | c.*2258_*2259insA | 3_prime_UTR | Exon 10 of 10 | NP_000094.2 | |||
| CYP19A1 | NM_001347248.1 | c.*2258_*2259insA | 3_prime_UTR | Exon 10 of 10 | NP_001334177.1 | P11511-1 | |||
| CYP19A1 | NM_001347249.2 | c.*2258_*2259insA | 3_prime_UTR | Exon 10 of 10 | NP_001334178.1 | P11511-1 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CYP19A1 | ENST00000396402.6 | TSL:1 MANE Select | c.*2258_*2259insA | 3_prime_UTR | Exon 10 of 10 | ENSP00000379683.1 | P11511-1 | ||
| MIR4713HG | ENST00000559909.1 | TSL:4 | n.195-69434_195-69433insT | intron | N/A | ||||
| MIR4713HG | ENST00000805692.1 | n.279-69434_279-69433insT | intron | N/A |
Frequencies
GnomAD3 genomes AF: 0.459 AC: 69620AN: 151802Hom.: 16487 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
69620
AN:
151802
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.500 AC: 1AN: 2Hom.: 0 Cov.: 0 AF XY: 0.500 AC XY: 1AN XY: 2 show subpopulations
GnomAD4 exome
AF:
AC:
1
AN:
2
Hom.:
Cov.:
0
AF XY:
AC XY:
1
AN XY:
2
show subpopulations
African (AFR)
AF:
AC:
1
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.458 AC: 69648AN: 151920Hom.: 16488 Cov.: 0 AF XY: 0.454 AC XY: 33754AN XY: 74276 show subpopulations
GnomAD4 genome
AF:
AC:
69648
AN:
151920
Hom.:
Cov.:
0
AF XY:
AC XY:
33754
AN XY:
74276
show subpopulations
African (AFR)
AF:
AC:
14744
AN:
41432
American (AMR)
AF:
AC:
5887
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
AC:
1913
AN:
3472
East Asian (EAS)
AF:
AC:
2567
AN:
5156
South Asian (SAS)
AF:
AC:
1613
AN:
4818
European-Finnish (FIN)
AF:
AC:
5519
AN:
10552
Middle Eastern (MID)
AF:
AC:
120
AN:
294
European-Non Finnish (NFE)
AF:
AC:
35833
AN:
67918
Other (OTH)
AF:
AC:
975
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1881
3762
5643
7524
9405
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
634
1268
1902
2536
3170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1329
AN:
3478
ClinVar
ClinVar submissions as Germline
View on ClinVar Significance:Benign
Revision:criteria provided, single submitter
Pathogenic
VUS
Benign
Condition
-
-
1
Aromatase deficiency (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.